or
forgot password
  • cancer clinical trials in new haven, CT

  • Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
    Yale University Smilow Cancer Hospital
    New Haven, Connecticut 06520
    Colorectal Cancer
    Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
    Yale University
    New Haven, Connecticut 06520
    Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
    Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer
    Smilow Cancer Center
    New Haven, Connecticut 06510
    Metastatic Pancreatic Cancer, Pancreatic Cancer
    Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    Yale University
    New Haven, Connecticut 06520
    BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Sodium Management in Acute Neurological Injury
    Yale-New Haven Hospital
    New Haven, Connecticut 06504
    The Focus of the Study is to Understand the Current Practice of Sodium Management in Patients With Acute Neurological Injury.
    A Pilot Study of Sorafenib Examining Biomarkers in Refractory or Relapsed T-Cell Lymphoma Patients
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    T Cell Lymphoma
    Phase 1/2, Open-label, Dose-escalation Study of ISIS-STAT3Rx, Administered to Patients With Advanced Cancers
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Advanced Cancers, DLBCL, Lymphoma
    Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Head and Neck Neoplasms
    Safety Study of Anti-Programmed Death-1 in Hematologic Malignancy
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Non-Hodgkin's Lymphoma, Hodgkin Lymphoma, Multiple Myeloma, Chronic Myelogenous Leukemia
    Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
    Yale University
    New Haven, Connecticut 06520
    Childhood Central Nervous System Choriocarcinoma, Childhood Central Nervous System Embryonal Tumor, Childhood Central Nervous System Germ Cell Tumor, Childhood Central Nervous System Germinoma, Childhood Central Nervous System Mixed Germ Cell Tumor, Childhood Central Nervous System Teratoma, Childhood Central Nervous System Yolk Sac Tumor, Childhood Pineal Parenchymal Tumor
    Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Colorectal Cancer
    A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
    Yale University School of Medicine Yale Univ
    New Haven, Connecticut 06520
    Breast Cancer
    A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in Situ
    Erin Hofstatter, MD
    New Haven, Connecticut 06510
    Ductal Carcinoma in Situ
    Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Metastatic Breast Cancer, Gastrointestinal Tumors
    4D Image-Guided Partial Breast Radiation in Stage 0 and l Breast Cancer
    Yale New Haven Hospital
    New Haven, Connecticut 06520
    Breast Cancer
    Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa
    Yale School of Medicine
    New Haven, Connecticut 06510
    Breast Cancer
    Study of BMS-936558 Compared to Docetaxel in Previously Treated Advanced or Metastatic Non-squamous NSCLC
    Yale University
    New Haven, Connecticut 06520
    Non-Squamous Cell Non-small Cell Lung Cancer
    LDK378 in Adult Patients With ALK-activated NSCLC Previously Treated With Chemotherapy and Crizotinib
    Yale University School of Medicine Dept Oncology
    New Haven, Connecticut 06520
    Non-Small Cell Lung Cancer
    A Phase III Study of Oral LDE225 Versus (vs) Temozolomide (TMZ) in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)
    Yale University School of Medicine Dept of Oncology
    New Haven, Connecticut 06520
    Medulloblastoma
    A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib
    Yale University School of Medicine-Yale Cancer Center
    New Haven, Connecticut 06519
    Non-small Cell Lung Cancer(NSCLC)
    Pilot Study of Effect of Sorafenib on Portal Pressure
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Clinically Significant Portal Hypertension
    Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL
    Yale University School of Medicine - Yale Cancer Center
    New Haven, Connecticut 06520
    Cutaneous T-Cell Lymphoma
    Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
    Yale University
    New Haven, Connecticut 06520
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    A Comparative Study of Occlusive Heat Patch in the Treatment of Warts
    Yale School of Medicine
    New Haven, Connecticut 06510
    Verruca (Warts)
    ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell
    Phase 2 Study of Neoadjuvant Vemurafenib in Melanoma Patients With Untreated Brain Metastases
    Smilow Cancer Hospital at Yale New Haven
    New Haven, Connecticut 06510
    Melanoma [C04.557.465.625.650.510]
    Phase 1/2 Dose-Escalation, Safety, PK & PD Study of BVD-523, an ERK 1/2 Inhibitor, in Patients With Advanced Malignancies
    Sarah Cannon Research Institute/Yale Cancer Center
    New Haven, Connecticut 06520
    Advanced Solid Tumors
    A Twelve Week Safety and Efficacy Study in Rosacea
    The Savin Center, PC
    New Haven, Connecticut 06511
    Papulopustular Rosacea
    Circulating Tumor Cells in Non-Small Cell Lung Carcinoma
    Yale University
    New Haven, Connecticut 06520
    Primary Lung Cancer
    Breast Cancer Molecular Analysis Protocol
    Smilow Hospital Breast Center
    New Haven, Connecticut 06520-8032
    Metastatic Breast Cancer
    Vibration Response Imaging (VRI) in Patients Who Are Potential Candidates for Surgical Resection
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Lung Cancer
    oncoFISH Cervical Test for Detection of 3q26 Region Gain
    Ikonisys
    New Haven, Connecticut 06511
    Cervical Cancer, LSIL
    Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Carcinoma of Unknown Primary, Head and Neck Cancer
    Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Kidney Cancer
    Aminocamptothecin in Treating Patients With T-Cell Lymphoma
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Lymphoma
    Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Breast Cancer
    Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Leukemia
    Perillyl Alcohol in Treating Patients With Refractory Cancer
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific
    Combination Chemotherapy in Treating Children With Progressive Brain Tumors
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Brain and Central Nervous System Tumors
    Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Cardiac Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Combination Chemotherapy in Treating Children With Neuroblastoma
    Yale Comprehensive Cancer Center at Yale University School of Medicine
    New Haven, Connecticut 06520-8064
    Neuroblastoma
    Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Lung Cancer
    Surgery in Treating Children With Neuroblastoma
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Neuroblastoma
    Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Leukemia
    Vinorelbine in Treating Children With Recurrent or Refractory Cancers
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Brain and Central Nervous System Tumors, Neuroblastoma, Sarcoma
    Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Brain and Central Nervous System Tumors
    Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Stage IV Melanoma, Stage III Melanoma, Recurrent Melanoma
    Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Sarcoma
    Bexarotene in Treating Patients With Metastatic Breast Cancer
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Breast Cancer
    Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Head and Neck Cancer
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Yale Comprehensive Cancer Center

    Trial Locations
    Yale Comprehensive Cancer Center
    Hospital of St. Raphael
    Breast Cancer
    Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome
    Yale Comprehensive Cancer Center at Yale University School of Medicine
    New Haven, Connecticut 06520-8064
    Lymphoma
    Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Esophageal Cancer, Gastric Cancer
    3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Unspecified Adult Solid Tumor, Protocol Specific
    Longitudinal and Biological Study of Childhood Disintegrative Disorder
    Yale Child Study Center
    New Haven, Connecticut 06520
    Pervasive Child Development Disorders, Autism
    Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Anemia, Head and Neck Cancer
    Docetaxel and Irinotecan in Treating Patients With Advanced Solid Tumors
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Unspecified Adult Solid Tumor, Protocol Specific